Reader-exclusive · 10% off DoNotAge SIRT6Activator® Review on DoNotAge CODE BB10
DoNotAge SIRT6Activator® Review

DoNotAge · SIRT6 Activator · Physician-reviewed

DoNotAge SIRT6Activator Review — What the Fucoidan Evidence Actually Shows

RECOMMENDED Product Review 23 min read Last verified 1 Sep 2026
4.3/5 Reflects the strongest, most directly replicated SIRT6-activation evidence base of any product in this category: three independent research groups confirm the core mechanism, and two 2025 studies used this manufacturer's own material with clean SIRT6-knockout controls. Dosing tiers match published research ranges rather than a generic serving size. The rating sits just below the ceiling because no SIRT6-activating supplement, industry-wide, yet has human trial data — a category-wide gap, not one specific to this product.

What stands out

  • Built around the specific fucoidan species and extraction shown to activate SIRT6 selectively, not a generic seaweed extract
  • Two independent 2025 studies, using this manufacturer's own supplied material, show measurable effects in aged mice
  • Three dosing tiers (800 mg, 1,600 mg, 2,400 mg) let you match published research ranges rather than a single fixed dose
  • Vegan capsule with a short excipient list, manufactured to GMP and ISO 9001 standards
  • A senior scientist behind the key supporting studies sits on DoNotAge's advisory board — disclosed, and a sign the manufacturer is funding real research rather than only marketing

Things to know first

  • No human clinical trial of fucoidan-driven SIRT6 activation exists yet — every finding here is from cells or mice
  • The mouse dose that extended lifespan works out to roughly 400 times DoNotAge's standard human dose on a body-weight basis; no human dose has been established from trial data
  • Effects are slow and biological — plan for months, not weeks, before expecting any noticeable change
  • The 14-day money-back guarantee is shorter than some competitors offer, and is tiered (full refund unopened, 50% if opened)

Key takeaways

  • Fucoidan from Fucus vesiculosus is the only compound so far shown to directly and selectively activate SIRT6, a DNA-repair enzyme that declines with age.
  • Two independent 2025 mouse studies, using DoNotAge's own supplied fucoidan, found extended lifespan in males, reduced frailty in both sexes, and confirmed the effect requires SIRT6.
  • The mouse dose that extended lifespan works out to roughly 400 times DoNotAge's standard human dose on a body-weight basis — no human dose has been established.
  • No human clinical trial of a SIRT6-activating supplement has been completed yet; every SIRT6 activator on the market, including this one, rests on preclinical evidence.
  • DoNotAge offers three dosing tiers (800 mg, 1,600 mg and 2,400 mg daily) and a shorter, tiered 14-day money-back guarantee than its main named competitor.
  • A scientist on DoNotAge's advisory board co-authored the key supporting studies using DoNotAge-supplied material — a disclosed relationship worth knowing, not a reason to dismiss the biochemistry.

Bottom line

SIRT6Activator is built on the strongest fucoidan-SIRT6 evidence base of any product we've reviewed in this category, including two 2025 mouse studies that used this exact manufacturer's material. The mechanism is real and well replicated. What's missing, industry-wide, is any human trial — so treat this as a well-evidenced bet on a preclinical pathway, not a proven intervention.

Evidence last checked 1 September 2026 against 36 live papers in the Biohack Blueprint SIRT6 Data Center.
Reader-exclusive

DoNotAge SIRT6Activator® Review — via DoNotAge

Use code 10% off
  • 14-day money-back guarantee
  • One 366-capsule container covers 61–183 days depending on your chosen dose tier (about 61 days at 2,400 mg/day, up to 183 days at 800 mg/day); subscriptions ship the matching number of containers for a 12-month supply supply per bottle
  • Subscribe & save available
  • Fast shipping from DoNotAge
Get 10% off on DoNotAge with BB10 →

DoNotAge handles pricing, fulfilment, and customer support for this product. Our independent editorial oversight is funded, in part, by commission on purchases made through reader links — it does not affect our evidence grading or editorial verdict.

Physician-reviewed GMP & ISO 9001 manufactured Vegan capsule Data Center cross-checked

Who this is for

Good fit if you're...

Longevity stack builders

Adults already taking NAD+ precursors or resveratrol who want to add a DNA-repair-focused compound working through a distinct pathway

Evidence-comfortable early adopters

Readers comfortable acting on strong preclinical and mouse evidence while human trials of SIRT6 activators are still years away

DNA-repair and senescence focused

Adults over about 40 specifically interested in the DNA-repair and cellular-senescence angle on ageing, rather than a general multivitamin approach

Vegans and vegetarians

The vegetable-cellulose capsule and plant-derived active ingredient suit a fully plant-based routine

Probably not for you if...

Anyone wanting fast, felt effects

Consider waiting if you're expecting a stimulant-like or immediately noticeable change — this is a slow, structural intervention

Anyone on blood-thinning medication

Consider waiting if you take warfarin, a DOAC, or antiplatelet medication, until you've checked with your doctor

Pregnant, breastfeeding, or under 18

Consider waiting — no safety data exist for these groups

Readers who want human-trial certainty first

Consider waiting if you want to see completed human trial data before trying a supplement — that evidence doesn't yet exist for any SIRT6 activator on the market, including this one

Ready to try it for yourself? Use code BB10 for 10% off DoNotAge SIRT6Activator® Review on DoNotAge.

Shop on DoNotAge →

Key facts & composition

Active compound Fucoidan (sulphated polysaccharide) Purified extract of Fucus vesiculosus, a brown seaweed
Dose per capsule 400 mg Standard daily serving is 4 capsules (1,600 mg)
Daily dose options 800 mg, 1,600 mg or 2,400 mg Split into two doses, taken with the midday and evening meals
Capsule format Vegetable cellulose (HPMC) Vegan, no gelatin
Source species Fucus vesiculosus The species used directly in the founding SIRT6-activation research
Testing In-house and third-party lab tested Checked for purity and potency before release
Diet suitability Vegan, non-GMO No animal-derived ingredients or declared common allergens

Composition

Ingredient Amount Form Source
Fucoidan (from Fucus vesiculosus) 400 mg per capsule; 1,600 mg at the standard daily serving of 4 capsules Purified sulphated polysaccharide extract Fucus vesiculosus (bladderwrack), a brown seaweed

Not all fucoidan behaves the same way. The 2025 mouse studies behind this product tested several fucoidan sources side by side, and found that a crude Fucus vesiculosus preparation and a Macrocystis pyrifera (giant kelp) extract failed to activate SIRT6, while purified Fucus vesiculosus, Undaria pinnatifida, and Cladosiphon okamuranus extracts all worked.

The species and the purification method both matter. That is worth knowing before assuming any "fucoidan" supplement on the shelf does the same job as the one tested here.

How it works

SIRT6Activator's case rests on a specific, well-replicated biochemical finding: fucoidan from a particular seaweed species switches on the SIRT6 enzyme. Here's how that plays out, from the test tube to the mouse cage.

1

A seaweed compound with a specific target

SIRT6 is an enzyme that sits inside the nucleus of your cells. It does two main jobs: it removes chemical tags from proteins called histones, and it attaches a different chemical tag, called mono-ADP-ribose, onto DNA-repair proteins. Both jobs help keep your genome stable.

Fucoidan is a sulphated sugar chain found in brown seaweed. In 2017, researchers screened five seaweed species against purified SIRT6 in a test tube and found that fucoidan from Fucus distichus and Fucus vesiculosus switched the enzyme on, with no effect on the three other sirtuins tested alongside it.

Two 2025 studies, run independently at the University of Rochester and using DoNotAge's own supplied Fucus vesiculosus fucoidan, confirmed the effect in living mice and traced it back to SIRT6 itself: when the researchers repeated the experiment in mice with the SIRT6 gene deleted, fucoidan's benefits disappeared.

2

SIRT6 and DNA repair

Every day, your cells pick up small amounts of DNA damage from ordinary metabolism, oxidative stress, and the environment. SIRT6 helps two separate repair pathways deal with it: base excision repair, which fixes everyday chemical damage, and double-strand break repair, which fixes more serious breaks in the DNA helix.

Mice bred without any SIRT6 show sharply reduced repair capacity and die of an ageing-like syndrome within weeks. Later work showed SIRT6 physically binds broken DNA within seconds of damage occurring, and separately activates a repair protein called PARP1 by tagging it directly.

This is one of the best-replicated findings in the SIRT6 literature, built up across independent laboratories over nearly two decades. It is also entirely preclinical: every study behind it was done in cells or mice, not in people.

3

Clearing out worn-out cells

As tissue ages, some cells stop dividing but do not die. These "senescent" cells build up and release inflammatory signals that damage the healthy tissue around them.

A 2025 screen of fucoidan variants found that the specific Fucus vesiculosus extract used in DoNotAge's product reduced markers of cell senescence and inflammatory signalling in the kidneys of naturally aged mice, and reduced ageing symptoms in a fast-ageing mouse strain, after several weeks of dosing.

The effect was partly, not fully, dependent on SIRT6 in follow-up cell experiments, which means fucoidan may act through more than one route. This is a single, not-yet-peer-reviewed study, so treat it as an early but promising signal rather than a settled finding.

4

What more SIRT6 activity does downstream

Separately from the fucoidan work, a body of research has asked what happens when mice are genetically engineered to carry extra SIRT6 from birth. The pattern that emerges is consistent: better blood sugar control in old age, steadier energy metabolism in the liver, and longer median lifespan in male mice across three independent research groups.

A 2026 study went a step further, showing that adding SIRT6 to the livers of already-old mice partly reversed age-related changes to how their DNA is packaged, alongside reduced inflammatory gene activity.

None of this downstream work used fucoidan directly. It used genetic overexpression of SIRT6, a different way of raising SIRT6 activity. It is included here because it strengthens the case that more SIRT6 activity is broadly beneficial in ageing mice, which supports the case for fucoidan as one way to raise that activity, without itself being a fucoidan-specific finding.

This review draws on 15 peer-reviewed papers indexed in our SIRT6 Activator Data Center →

The evidence

Each claim below is graded A to F: A means consistent, replicated evidence; D means the mechanism is plausible but direct proof is thin or missing. Grades stay honest even where DoNotAge's own marketing goes further.

A

Activates SIRT6 directly and selectively

Tier 3

Three independent papers, from three different research groups, agree on this point: fucoidan from Fucus vesiculosus switches SIRT6 on, and does so specifically. The original 2017 discovery paper found a roughly 355-fold increase in SIRT6 activity in a test tube, with no effect on three other sirtuins tested alongside it.

Two 2025 papers, using DoNotAge's own supplied material, confirmed the effect in living mouse tissue and in human cell lines, and showed the benefit disappears in mice with the SIRT6 gene removed. Independent replication with a clean mechanistic knockout is about as strong as preclinical supplement evidence gets.

This is still laboratory and animal evidence, not a human trial. The grade reflects how clean and reproducible the mechanism is, not proof of a clinical outcome in people.

Rahnasto-Rilla MK et al. 2017, Biashad SA et al. 2025, Robbins PD et al. 2025

B

Extends lifespan and reduces frailty in aged mice

Tier 3

In 2025, aged mice given DoNotAge's fucoidan from 15 months of age (roughly late-middle-age for a mouse) lived 13% longer at the median if they were male, and showed slower frailty progression in both sexes. Female median lifespan rose 3%, but that result did not reach statistical significance.

The effect required SIRT6: mice with the SIRT6 gene deleted showed no lifespan benefit from the same fucoidan diet at all, which is strong evidence the pathway, not some unrelated effect of the seaweed extract, is doing the work.

This finding is reinforced by older, separate research showing mice genetically engineered to carry extra SIRT6 from birth also live longer, in three independent labs. The grade is B rather than A because the direct fucoidan-lifespan finding is a single study, not yet peer-reviewed, with a sex-asymmetric result and no human data of any kind.

Biashad SA et al. 2025, Kanfi Y et al. 2012, Roichman A et al. 2021

B

Supports DNA repair and genomic stability

Tier 3

This is the deepest and most replicated part of the SIRT6 literature. Independent laboratories going back to 2006 have shown SIRT6 is required for cells to repair everyday DNA damage, that it physically detects broken DNA within seconds, and that it switches on a major repair protein called PARP1 by tagging it directly.

Cross-species comparisons across 18 rodent species found that how well a species' own SIRT6 boosts DNA repair tracks closely with how long that species lives, strengthening the case that this mechanism matters for ageing generally, not just in a lab dish.

The grade is B, not A, because none of this work has been done in humans, and none of it directly tests fucoidan supplementation as the intervention — it establishes what SIRT6 does, which the fucoidan-activation claim above builds on.

Mostoslavsky R et al. 2006, Mao Z et al. 2011, Tian X et al. 2019, Onn L et al. 2020, Michael Van Meter et al. 2016

C

May help clear or quiet senescent cells

Tier 3

A single 2025 study found that the Fucus vesiculosus fucoidan used in this product reduced markers of cell senescence and inflammatory signalling in the kidneys of aged mice, and eased symptoms in a fast-ageing mouse strain over several weeks.

This is a real and specific finding, not a generic seaweed claim. But it comes from one laboratory, in a preprint that has not yet been peer-reviewed, and the effect was only partly dependent on SIRT6 in follow-up experiments — meaning fucoidan may be doing some of this work through a different route entirely.

What would raise this grade: independent replication, and a peer-reviewed version of the paper confirming the effect size holds up.

Robbins PD et al. 2025

C

Supports metabolic efficiency in ageing tissue

Tier 3

Mice engineered to carry extra SIRT6 keep making new glucose efficiently in the liver into old age, when normal mice lose that ability, and separately keep youthful levels of a signalling gas called hydrogen sulphide that supports metabolic health.

Both findings are genuinely about SIRT6 activity and ageing metabolism, and both are mechanistically well worked out. Neither, however, was produced using fucoidan — they used genetic overexpression of SIRT6 from birth, a different way of raising SIRT6 activity to the fucoidan supplement being reviewed here.

The grade reflects a real and plausible mechanism with a gap between the intervention studied (genetic) and the intervention sold (a fucoidan supplement) that has not yet been closed by a direct study.

Roichman A et al. 2021, Touitou N et al. 2025

D

Cognitive and brain health support

Tier 4

Mice with SIRT6 deleted specifically in the brain develop signs of accelerated brain ageing by four months old: more DNA damage, more cell death, and a build-up of a modified form of the Tau protein that is a hallmark of Alzheimer's disease. Human Alzheimer's brain tissue shows markedly reduced SIRT6 compared with age-matched healthy tissue.

This tells us that losing SIRT6 harms the brain. It does not tell us that adding more SIRT6 activity, via fucoidan or anything else, improves cognition in an intact brain — no study has tested that specific question, in mice or in people.

The D grade reflects that gap honestly. This is a mechanistically plausible, worth-watching area of research, not yet a demonstrated benefit of taking this supplement.

Kaluski S et al. 2017, Smirnov D et al. 2023

The evidence stacks up. Use code BB10 for 10% off DoNotAge SIRT6Activator® Review on DoNotAge.

Shop on DoNotAge →

How it compares

DoNotAge SIRT6Activator® ReviewProHealth Sirtuin 6 Activator Generic/unbranded fucoidan
Active ingredient Fucus vesiculosus fucoidan, single species, matched to the SIRT6-activation research Fucus vesiculosus + Undaria pinnatifida blend (whole-plant extract and powder) Species and extraction method frequently undisclosed
Daily fucoidan dose 800–2,400 mg/day across three tiers 400 mg/day (1 capsule) Varies widely; often below published research ranges
Published research using this exact formulation Yes — DoNotAge-supplied fucoidan was used directly in the 2025 mouse lifespan and senescence studies No published study uses ProHealth's specific blend No
Third-party testing transparency In-house plus third-party lab verification Three rounds of independent third-party testing, with results published for the customer to view Rarely disclosed
Money-back guarantee 14 days (full refund unopened, 50% refund if opened) 100 days, no questions asked Varies, often none
Capsule and excipients Vegetable cellulose capsule only, no additional fillers declared Vegetable cellulose capsule plus microcrystalline cellulose and bamboo silica Varies by manufacturer
Subscription flexibility Three dose tiers, annual shipment, cancel anytime Single dose option, subscribe-and-save available Not applicable

One of the strongest evidence profiles in its category. Use code BB10 for 10% off DoNotAge SIRT6Activator® Review on DoNotAge.

Shop on DoNotAge →

Clinical pharmacology

DoNotAge sells SIRT6Activator across three dose tiers. None of them come close to the dose used in the mouse lifespan study — a gap worth understanding before you decide how much to take.

Dose tiers

TierDoseFrequencyDurationNotes
Starter — 800 mg/day 2 capsules (800 mg) daily Twice daily, with food Ongoing daily use

1 capsule before the midday meal, 1 capsule before the evening meal.
Standard — 1,600 mg/day 4 capsules (1,600 mg) daily Twice daily, with food Ongoing daily use

DoNotAge's standard recommended dose. 2 capsules before the midday meal, 2 capsules before the evening meal.
Higher dose — 2,400 mg/day 6 capsules (2,400 mg) daily Twice daily, with food Ongoing daily use

3 capsules before the midday meal, 3 capsules before the evening meal. Still well below the body-weight-adjusted dose used in the mouse lifespan study — see Clinical pharmacology.

From bench to bedside

PathwayPreclinical findingHuman translationConfidence
Fucoidan-driven SIRT6 activation and DNA repair Fucoidan increases SIRT6 enzyme activity in purified protein assays, human cell lines, and mouse tissue, and the effect is lost when SIRT6 is genetically removed. The core biochemistry has been shown in human cell lines, but no study has measured SIRT6 activity or DNA repair capacity in a person taking oral fucoidan. Moderate
Fucoidan and mouse lifespan Oral fucoidan extended median lifespan by 13% in male mice and reduced frailty in both sexes, with no benefit in SIRT6-knockout mice. Mouse lifespan interventions have a mixed track record of translating to humans. No fucoidan human trial exists, and the effective mouse dose (see Dosing) is far higher, per kilogram, than the human serving sold here. Low
SIRT6 and human genetic longevity A rare SIRT6 gene variant is modestly more common in Ashkenazi Jewish centenarians and enhances SIRT6's DNA-repair-relevant enzyme activity in the laboratory. This is genuine human data, but it is association, not intervention. It shows naturally higher SIRT6 activity correlates with exceptional longevity in this population; it does not show that supplementing to raise SIRT6 activity in adulthood reproduces that outcome. Moderate
Senescent cell clearance Fucoidan reduced senescence and inflammatory markers in the kidneys of naturally aged mice and eased symptoms in a fast-ageing mouse strain. Consistent in direction with the wider senolytic literature (fisetin, quercetin), but this specific fucoidan-senescence finding has not been tested in any other species, including humans. Low

Drug interactions

Caution advised

Anticoagulant and antiplatelet medications

Sulphated polysaccharides like fucoidan have documented anticoagulant and antiplatelet activity in the wider pharmacology literature, separate from the SIRT6-specific evidence reviewed above.

Recommendation:

If you take warfarin, a direct oral anticoagulant, aspirin, or another blood-thinning medication, speak with your doctor before starting SIRT6Activator. This is a precautionary, class-level recommendation rather than a finding from a SIRT6-specific trial — DoNotAge's own guidance is similarly general, advising anyone on prescription medication to check with a healthcare provider first.

Bioavailability tips

DoNotAge recommends splitting the daily dose into two, taken with the midday and evening meals, rather than as a single dose. There's no published bioavailability data specific to this product to confirm whether food timing measurably changes absorption; this is the manufacturer's own dosing protocol, matched to the split-dose design used in the underlying mouse studies.

Special populations

PopulationRecommendationRationale
Pregnancy and breastfeeding Speak to your doctor before use

No safety data exist for fucoidan supplementation during pregnancy or breastfeeding, in this product's evidence base or the wider literature. DoNotAge's own guidance takes the same precautionary position.
Under 18 Not recommended without paediatric medical advice

All of the research behind this product, human and animal, was conducted in adults or adult mice. There is no dosing or safety information for younger people.
Pre-existing thyroid disease Check with your doctor first

Fucoidan is extracted from seaweed, a food group with naturally variable iodine content. DoNotAge's product page does not publish an iodine assay for this extract, so anyone with a thyroid condition should confirm suitability with their doctor before starting.

Therapeutic positioning

SIRT6Activator sits in a specific corner of the longevity-supplement landscape. Here's how it relates to the other compounds people commonly stack alongside it.

NMN and other NAD+ precursors

Different longevity pathway Complementary, not competing

NMN raises NAD+, the fuel SIRT6 and other sirtuins need to function at all, but does not activate SIRT6 directly. DoNotAge markets the two as complementary, and the mechanisms do not overlap, so there is no obvious reason to choose one over the other rather than considering them separately.

Resveratrol

Different sirtuin target Different target, not a substitute

Resveratrol is best known as a SIRT1 activator, not a SIRT6 activator. The two sirtuins have overlapping but distinct roles, so resveratrol is not a substitute for a SIRT6-specific compound.

Senolytics (fisetin, quercetin)

Different mechanism, overlapping goal Different mechanism, earlier evidence stage

Senolytics work by selectively killing senescent cells outright. Fucoidan's senescence-related effect, where it exists, appears to work more by quieting senescent cells' inflammatory output than by killing them, and the evidence for that specific effect is earlier-stage than the fisetin and quercetin senolytic literature.

Small-molecule SIRT6 activators (MDL-800 and similar)

Same target, research-stage only Not consumer-available

Synthetic compounds like MDL-800 activate SIRT6 more potently than fucoidan in laboratory assays and have shown benefit in cell and animal models of cancer and cartilage ageing. None is available as a consumer product; they remain research tools and early drug-development candidates.

Caloric restriction and, to a lesser extent, fasting are the best-established ways to raise SIRT6-adjacent longevity signalling in mammals. A SIRT6-activating supplement is not a substitute for either — it is, at best, a partial and much less studied mimic of one specific downstream pathway.

SIRT6Activator is a supplement, not a medical treatment. It does not replace a cancer screening programme, a bone-density scan, or medical management of an existing condition. Nothing on this page should be read as a claim to diagnose, treat, cure, or prevent any disease.

About buying through us

Why does Biohack Blueprint recommend a product it earns commission on?

We're upfront about it: buying through our link earns Biohack Blueprint a commission, and DoNotAge gives readers 10% off with the code BB10. That relationship doesn't change what the evidence table above says. The grades are set before commercial considerations, and a D-grade claim stays a D-grade claim whether or not we're an affiliate partner.

Does the affiliate relationship change the evidence grading on this page?

No. Every claim on this page is graded against the same A-to-F framework we use for every product review on this site, based on what the cited papers actually show. Where DoNotAge's own marketing overstates what a study found, that gap is called out directly rather than smoothed over.

Is the DoNotAge-funded research a conflict of interest?

It's a disclosed relationship worth knowing about, not a reason to dismiss the biochemistry. The senior scientist behind the 2025 mouse studies sits on DoNotAge's scientific advisory board, and the fucoidan tested was DoNotAge-supplied. That's stated plainly in the papers' own competing-interest sections. The knockout-mouse control in the same studies — showing no benefit when SIRT6 is genetically removed — is a meaningful check against simple bias, but independent replication by an unaffiliated lab would strengthen the case further.

Why is the money-back guarantee shorter than some competitors offer?

DoNotAge offers a 14-day guarantee (full refund unopened, 50% refund if opened), which is shorter than ProHealth's 100-day guarantee on its own SIRT6 activator. We've said so plainly in the comparison table above rather than leaving it out.

What happens if the evidence changes?

This page carries a last-verified date and a revision history. If the Biashad or Robbins preprints are published in peer-reviewed form with different numbers, or if a human trial reports results, we'll update the evidence table and the verdict to match — that's the point of dating and revising the page rather than publishing it once and leaving it static.

Reader questions

What is SIRT6 and why does activating it matter?

SIRT6 is an enzyme in your cells that helps repair DNA damage and regulate metabolism. Its activity naturally declines with age, and mice bred without it age very quickly. Several independent research groups have found that raising SIRT6 activity, by different means, is linked to better DNA repair capacity and longer lifespan in mice.

Does fucoidan actually reach and activate SIRT6 in the body?

In a test tube, yes, strongly and specifically. In living mice, dietary fucoidan produced measurable downstream effects — lower DNA damage markers, reduced inflammatory gene activity, extended lifespan in males — that disappeared in mice without SIRT6, which is good evidence the pathway is engaged in a whole animal, not just in a dish. Exactly how a large sugar molecule like fucoidan influences an enzyme sitting inside the cell nucleus is not fully worked out; the study authors themselves flag this as an open question.

How long before I'd notice anything?

Realistically, you won't feel SIRT6 activation the way you'd feel a stimulant. This is a structural, biological process. Give it several months before assessing, and don't expect a subjective marker of whether it's working — the underlying biology isn't the kind you can feel day to day.

Can I take SIRT6Activator with NMN or resveratrol?

There's no known interaction, and the mechanisms don't overlap. NMN raises NAD+, resveratrol targets a different sirtuin (SIRT1), and fucoidan targets SIRT6 directly. DoNotAge markets the three as complementary, which is mechanistically reasonable, though no study has tested the combination directly.

Is SIRT6Activator safe with blood thinners?

Speak to your doctor first. Sulphated polysaccharides like fucoidan have documented anticoagulant and antiplatelet activity in the broader pharmacology literature, separate from the SIRT6 evidence reviewed on this page. This is a precautionary, class-level recommendation rather than a finding specific to this product.

Is it safe during pregnancy?

No safety data exist for fucoidan supplementation during pregnancy or breastfeeding. Speak to your doctor before starting, and DoNotAge's own guidance takes the same precautionary position.

Editorial credibility

Portrait of Dr. Khaled Mahmoud, ICU physician and founder of Biohack Blueprint

Author

Dr. Khaled Mahmoud, MBBCh

MBBCh

Critical Care Medicine, Longevity Science & Editorial Direction

Portrait of Dr. Amr Nassar, cardiometabolic and musculoskeletal reviewer for Biohack Blueprint

Reviewer

Dr. Amr Nassar, PhD

MBBCh, PhD, General Surgery, Cardiometabolic Medicine, Musculoskeletal Research

Cardiometabolic, Musculoskeletal, Gut & Bioavailability

Portrait of Dr. Abdulla Mostafa, neuroscience reviewer for Biohack Blueprint

Reviewer

Dr. Abdulla Mostafa, PhD

MBBCh, PhD, Neuroscience, Neurosurgery

Cellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology

Reflects the strongest, most directly replicated SIRT6-activation evidence base of any product in this category: three independent research groups confirm the core mechanism, and two 2025 studies used this manufacturer's own material with clean SIRT6-knockout controls. Dosing tiers match published research ranges rather than a generic serving size. The rating sits just below the ceiling because no SIRT6-activating supplement, industry-wide, yet has human trial data — a category-wide gap, not one specific to this product.

Related reading

medical-web-page

What Is SIRT6? A Clinician's Guide to the Longevity Sirtuin

 medical-web-page

SIRT6 Longevity: The Mouse Evidence, Human Data & 2026

 medical-web-page

SIRT6 DNA Repair: The Mechanism, Sensor Role & Age Decline

 medical-web-page

Fucoidan SIRT6 Activator: The Evidence, In Mice and Humans

 medical-web-page

SIRT6 Mechanism: Structure, 3 Enzyme Activities & Activators
  1. The Identification of a SIRT6 Activator from Brown Algae Fucus distichus Rahnasto-Rilla MK, McLoughlin P, Kulikowicz T, Doyle M, Bohr VA, Lahtela-Kakkonen M, Ferrucci L, Hayes M, Moaddel R (2017) . Marine Drugs Read on our Data CenterView on PubMed View on PMC DOI
  2. SIRT6 activator fucoidan extends healthspan and lifespan in aged wild-type mice Biashad SA, Hillpot E, Morandini F, Rechsteiner C, Paige V, Tombline G, Lee M, Zheng Z, Liang Y, Martinez J, Sieczkiewicz N, Zhang Z, Volobaev V, Firsanov D, Simon M, Zhang LJ, Robbins PD, Seluanov A, Gorbunova V (2025) . bioRxiv (preprint) Read on our Data Center DOI
  3. Fucoidans are senotherapeutics that enhance SIRT6-dependent DNA repair Robbins PD, Zhang L, Elsallabi O, Soto-Palma C, Bartz J, Salekeen R, Nunes A, Xu W, Lee K, Hughes B, Zhang B, Mohamed A, McGowan SJ, Angelini L, O'Kelly R, Biashad SA, Hillpot E, Morandini F, Seluanov A, Gorbunova V, Dong X, Niedernhofer LJ (2025) . Research Square (preprint, not peer-reviewed) Read on our Data CenterView on PubMed View on PMC DOI
  4. The sirtuin SIRT6 regulates lifespan in male mice Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, Bar-Joseph Z, Cohen HY (2012) . Nature Read on our Data CenterView on PubMed DOI
  5. Restoration of energy homeostasis by SIRT6 extends healthy lifespan Roichman A, Elhanati S, Aon MA, Abramovich I, Di Francesco A, Shahar Y, Avivi MY, Shurgi M, Rubinstein A, Wiesner Y, Shuchami A, Petrover Z, Lebenthal-Loinger I, Yaron O, Lyashkov A, Ubaida-Mohien C, Kanfi Y, Lerrer B, Fernández-Marcos PJ, Serrano M, Gottlieb E, de Cabo R, Cohen HY (2021) . Nature Communications Read on our Data CenterView on PubMed View on PMC DOI
  6. Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, Mills KD, Patel P, Hsu JT, Hong AL, Ford E, Cheng HL, Kennedy C, Nunez N, Bronson R, Frendewey D, Auerbach W, Valenzuela D, Karow M, Hottiger MO, Hursting S, Barrett JC, Guarente L, Mulligan R, Demple B, Yancopoulos GD, Alt FW (2006) . Cell Read on our Data CenterView on PubMed DOI
  7. SIRT6 promotes DNA repair under stress by activating PARP1 Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A, Gorbunova V (2011) . Science Read on our Data CenterView on PubMed View on PMC DOI
  8. SIRT6 is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived Species Tian X, Firsanov D, Zhang Z, Cheng Y, Luo L, Tombline G, Tan R, Simon M, Henderson S, Steffan J, Goldfarb A, Tam J, Cornwell A, Johnson A, Yang JN, Mao Z, Manta B, Dang W, Zhang Z, Vijg J, Wolfe A, Moody K, Kennedy BK, Bohmann D, Gladyshev VN, Seluanov A, Gorbunova V (2019) . Cell Read on our Data CenterView on PubMed View on PMC DOI
  9. SIRT6 is a DNA double-strand break sensor Onn L, Portillo M, Ilic S, Cleitman G, Stein D, Kaluski S, Shirat I, Slobodnik Z, Einav M, Erdel F, Akabayov B, Toiber D (2020) . eLife Read on our Data CenterView on PubMed View on PMC DOI
  10. JNK phosphorylates SIRT6 to stimulate DNA double-strand break repair in response to oxidative stress by recruiting PARP1 to DNA breaks Michael Van Meter, Matthew Simon, Gregory Tombline, Alfred May, Timothy D. Morello, Basil P. Hubbard, Katie Bredbenner, Rosa Park, David A. Sinclair, Vilhelm A. Bohr, Vera Gorbunova, Andrei Seluanov (2016) . Cell Reports Read on our Data CenterView on PubMed View on PMC DOI
  11. Sirt6 prevents the age-related decline of H2S through the control of one-carbon metabolism Touitou N, Nahum L, Feldman-Trabelsi S, Avivi MY, Aon MA, Naiman S, Rathaus M, Gertler AA, Roichman A, Berkman Dvir L, Bernier M, Banskota N, Beck L, Nagar R, Schwartz Z, Price NL, Harel M, Lerrer B, Ishii I, Senderowitz H, Moaddel R, Geiger T, de Cabo R, Cohen HY (2025) . Proceedings of the National Academy of Sciences of the United States of America Read on our Data CenterView on PubMed View on PMC DOI
  12. Neuroprotective functions for the histone deacetylase SIRT6 Kaluski S, Portillo M, Besnard A, Stein D, Einav M, Zhong L, Ueberham U, Arendt T, Mostoslavsky R, Sahay A, Toiber D (2017) . Cell Reports Read on our Data CenterView on PubMed View on PMC DOI
  13. SIRT6 is a key regulator of mitochondrial function in the brain Smirnov D, Eremenko E, Stein D, Kaluski S, Jasinska W, Cosentino C, Martinez-Pastor B, Brotman Y, Mostoslavsky R, Khrameeva E, Toiber D (2023) . Cell Death and Disease Read on our Data CenterView on PubMed View on PMC DOI
  14. SIRT6 overexpression counteracts chromatin aging in the male murine liver Ron Nagar, Zacharia Schwartz, Almog Katz, Noga Touitou, Efrat Sharon, Kobi Tzdaka, Odeya Waner, Noam Shalev, Rotem Clo, Leah Weiss, Benjamin Epstein, Michel Bernier, Roni B Shtark, Nirad Banskota, Kwan-Wood G Lam, Supriyo De, Nathan L Price, Batia Lerrer, Daniel Z Bar, Rafael de Cabo, Haim Y Cohen (2026) . Nature Communications Read on our Data CenterView on PubMed View on PMC DOI
  15. A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A Matthew Simon, Jiping Yang, Jonathan Gigas, Eric J Earley, Eric Hillpot, Lei Zhang, Maria Zagorulya, Greg Tombline, Michael Gilbert, Samantha L Yuen, Alexis Pope, Michael Van Meter, Stephan Emmrich, Denis Firsanov, Advait Athreya, Seyed Ali Biashad, Jeehae Han, Seungjin Ryu, Archana Tare, Yizhou Zhu, Adam Hudgins, Gil Atzmon, Nir Barzilai, Aaron Wolfe, Kelsey Moody, Benjamin A Garcia, David D Thomas, Paul D Robbins, Jan Vijg, Andrei Seluanov, Yousin Suh, Vera Gorbunova (2022) . The EMBO Journal Read on our Data CenterView on PubMed View on PMC DOI

Ready to try DoNotAge SIRT6Activator® Review?

Use code BB10 for 10% off on DoNotAge.

Shop DoNotAge SIRT6Activator® Review on DoNotAge →

14-day money-back guarantee

First published 1 Sep 2026 · Last verified 1 Sep 2026